Despite chemoprophylaxis, malaria remains a serious threat for large numbers of non-immune soldiers deployed in endemic areas. Five adult cases of severe falciparum malaria are reported. Three cases were complicated by multiorgan failure and one of these patients died from cerebral malaria. These cases serve to highlight issues, in an Australian intensive care unit, associated with the management of severe malaria, an uncommon disease in our country. The need for rapid diagnosis and commencement of appropriate treatment is paramount in preventing further morbidity and mortality. Understanding and management of malaria continues to evolve rapidly. The pathophysiology of acute lung injury, shock and brain injury associated with malaria are examined in light of recent research. This article discusses the current controversies of exchange blood transfusion and the use of the new artemisinin derivatives.
Malaria is one of the world's major health problems. Each year, there are 300 to 500 million new infections and over two million people die as a result of malaria 1 . Most of these deaths are caused by Plasmodium falciparum and occur in African children 1 . Infections with the other three species, P. vivax, P. ovale, or P. malariae rarely result in lifethreatening disease 2 .
Chloroquine-resistant falciparum malaria is endemic in East Timor. Malarial infection amongst large numbers of soldiers deployed in endemic areas has been an ongoing problem for many years. U.S. forces experienced 65,000 cases of malaria during the Vietnam war 3 . In 1993, in Somalia, during Operation Restore Hope, there were 48 cases of malaria recorded amongst the 30,000 deployed U.S. soldiers 4 .
Four patients were transferred to our institution over a seven-week period between December 1999 and February 2000. One patient presented 12 weeks later in May 2000. All patients were soldiers of the United Nations peacekeeping force in East Timor.
Dili, the capital of East Timor is 700 kilometres from Darwin.
In this report severe malaria was defined according to the 1990 World Health Organisation (WHO) criteria 5 . WHO defines severe malaria based on the presence of one of the following features and asexual forms of P. falciparum in the patient's blood:
1. Cerebral malaria defined as unrousable coma. 2. Severe normocytic anaemia-a haemoglobin less than 50 g/l. 3. Renal failure -a urine output less than 400 ml in 24 hours in adults failing to improve after rehydration and a serum creatinine of more than 260 µmol/l. 4. Pulmonary oedema or acute respiratory distress syndrome (ARDS). 5. Hypoglycaemia-a whole blood glucose concentration of less than 2.2 mmol/l. 6. Circulatory collapse or shock-a systolic blood pressure less than 70 mmHg in adults. 7. Spontaneous bleeding from gums, nose, gastrointestinal tract, other sites and/or substantial laboratory evidence of disseminated intravascular coagulation (DIC). 8. Repeated generalized convulsions. 9. Acidaemia-an arterial pH less than 7.25 or acidosis defined as a plasma bicarbonate concentration less than 15 mmol/l. 10. Macroscopic haemoglobinuria.
Other manifestations of severe malaria that do not themselves define severe malaria are mentioned by WHO and include 5 : 1. Impairment of consciousness less marked than unrousable coma. 2. Prostration or weakness so that the patient is unable to sit or walk. 3. Hyperparasitaemia (i.e., >5% in non-immune patients). 4. Jaundice-a serum bilirubin concentration greater than 50 µmol/l. 5. Hyperpyrexia-a rectal temperature of greater than 40°C. Table 1 outlines the pattern of organ involvement for each patient.
CASE HISTORIES Case 1
Patient 1, a 22-year-old Australian soldier, had been previously well and was taking daily 100 mg doxycycline prophylaxis. He developed a fever, headache and arthralgia but did not report his illness for three days. He was admitted to a field hospital, febrile to 40°C and clinically dehydrated. A thick film demonstrated P. falciparum malaria. The level of parasitaemia was described as "4 plus". A loading dose of quinine 1.2 g orally was administered and he was then transferred to a larger field hospital. Quinine was continued at 600 mg tds orally. On day one, he was noted to have marked facial oedema, dark urine and a respiratory wheeze.
On day 2 the patient awoke disorientated, jaundiced and in respiratory distress. His oxygen saturation was recorded at 73% on room air, which increased to 92% on 10 l/min oxygen from two oxygen concentrators working concurrently. The decision was made to transfer the patient to Dili.
While being loaded onto the aircraft the patient developed supraventricular tachycardia (SVT) to a rate of 190 bpm associated with a fall in his oxygen desaturation to 85% despite 12 l/min of oxygen via a face mask. Pharmacological cardioversion with verapamil 10 mg intravenously (IV) was successful.
In Dili, a diagnosis of pulmonary oedema was made and frusemide 40 mg IV was administered, resulting in a large diuresis and an improvement in his oxygen saturation. The patient remained normotensive with a blood pressure of 120/80 mmHg throughout this period. He remained confused and aggressive. Blood tests revealed creatinine 110 µmol/l, haemoglobin 125 g/l, platelet count 45 x 10 9 /l, bilirubin 150 µmol/l, prothrombin time (PT) 23 s and activated partial thromboplastin time (APTT) 68 s. There was no clinically apparent abnormal bleeding. The parasite count was measured at 700/µl. Artesunate 60 mg IV tds and oral doxycycline 100 mg bd were added to the oral quinine.
By day 5, the parasite count had fallen to less than 100/µl and less than 1% red blood cells (RBC) infected. He was then alert and orientated. Oxygen saturation remained at 96% on 4 l/min oxygen with a respiratory rate of 45 bpm. He was electively intubated for the 90 minute flight to Darwin.
Patient 1 arrived in our intensive care unit on the 8th day of his illness. His APACHE II score was 11. The blood pressure was 96/47 mmHg, central venous pressure (CVP) 8 mmHg and the P a O 2 /FiO 2 ratio was 260 mmHg. Chest X-ray demonstrated persistent extensive ground glass interstitial opacification. Table 2 lists laboratory results on admission. Renal function was normal. Platelet count and coagulation studies were improving. A 50% dextrose infusion was commenced to treat hypoglycaemia. He was jaundiced with liver function tests consistent with mild hepatic dysfunction. No parasites were demonstrated on repeat malarial films following the four-day course of oral quinine and 48 hours after commencing artesunate.
Patient 1 was extubated on the second day of his stay in our unit and discharged to the High Dependency Unit. Oral quinine was ceased nine days after being commenced. The seven-day course of doxycycline was completed. He was discharged after spending a total of four days in our hospital. Case 2 Patient 2, an 18-year-old Australian soldier, had been previously well and was taking daily 100 mg doxycycline prophylaxis. He had a three-day history of fever, rigors, nausea and diarrhoea before presenting to a field hospital. He was immediately air evacuated to Dili. On admission in Dili, he was febrile to 39.6°C, hypotensive with a blood pressure of 85/60 mmHg and oliguric. Thick and thin films demonstrated infection with both P. falciparum and P. vivax. Hyperparasitaemia was evident with a measured parasite load of 60% RBCs infected.
Intravenous quinine was commenced at 600 mg tds following a loading dose of 1.2 g. Artesunate was started at 60 mg IV tds with doxycycline 100 mg bd orally. CVP was 10 mmHg following aggressive fluid resuscitation. His urine output remained low at 10 ml/hr and his oxygen saturation deteriorated. Eleven hours after arriving in Dili he was intubated and transferred to Darwin.
On admission to our unit his APACHE II score was 22 on the fourth day of his illness. A petechial rash was noted. Noradrenaline and dobutamine were commenced at 0.05 µg/kg/min and 5µg/kg/min respectively to treat hypotension. His CVP was 13 mmHg and the P a O 2 /FiO 2 ratio was 140 mmHg. Chest X-ray findings were consistent with pulmonary oedema. He was acidotic, hyponatraemic, anaemic, profoundly thrombocytopaenic, mildly coagulopathic and jaundiced. His urea was 25mmol/l and creatinine was 403 µmol/l. Continuous veno-venous haemofiltration (CVVH) was commenced and 200 ml/h of fluid removed. A blood sugar of 1.5 mmol/l was treated with a 50% dextrose infusion. A thick film showed a parasite count of 14000/µl with 1% of RBCs infected by P. falciparum. Intravenous quinine 600 mg tds was continued for another 48 hours and then the dose was halved to 600 mg 16 hourly because of the renal failure. Doxycycline 100 mg PO bd was continued. Ceftriaxone 2 g IV daily and gentamicin 480 mg IV were administered to treat potential bacterial coinfection. Enteral feeding was started. On Day 1 in the unit, the noradrenaline was weaned, his oxygenation improved with fluid removal and the PT and APTT had returned to normal. He remained anuric. His platelet count was 9 x 10 9 /l. The parasite count had fallen to 400/µl. All inotropes were ceased by day 3. A widespread pulmonary infiltrate persisted on chest radiograph despite a daily negative fluid balance of two litres. The platelet count began to rise and bilirubin had fallen to 225 µmol/l. The thick film was negative after four days of quinine and three doses of artesunate.
The acute lung injury was slow to resolve. Repeat bronchial alveolar lavage specimens were culture negative. Intravenous antibiotics and quinine were ceased on day 6. Intermittent haemodialysis was commenced on day 7. Sedation was ceased on day 9 and he was extubated on day 10.
He was transferred to the renal ward on day 12 for intermittent haemodialysis, and then on to a southern hospital one week later, to be closer to his family. Six weeks later he no longer required haemodialysis.
Case 3
Patient 3, a 43-year-old Thai soldier, had been previously well and taking daily 100 mg doxycycline prophylaxis. He presented to a field hospital with a history of fever, headache, vomiting, diarrhoea and epigastric pain. Over the next five days the fever persisted. Daily malarial films were negative. On day 6, he became jaundiced and passed melaena. Thick and thin blood films were positive for P. falciparum. He was commenced on intravenous quinine 600 mg tds.
Haematemesis and melaena associated with abdominal distension developed on day seven. He received eight units of warm fresh group-specific whole blood from fellow soldiers in the field. His post-transfusion haemoglobin was 85 g/l.
The following day he was transferred to Dili and then to Darwin. He became agitated, hypotensive and hypoxic while being loaded onto the aeroplane at Dili airport. He was intubated on the airport tarmac. A dopamine infusion was started and several litres of crystalloid were given during the 90 minute flight.
On the eighth day after his initial presentation to the field hospital, he was admitted to our intensive care unit with an APACHE II score of 28. Following the establishment of arterial and central venous access, noradrenaline was commenced at 0.16 µg/kg/min. Dopamine was weaned and ceased. The CVP was 22 mmHg. The P a O 2 /FiO 2 ratio was 210 mmHg. Chest X-ray showed bilateral alveolar infiltrates and he had poor lung compliance. Urea was 30 mmol/l and creatinine was 625 µmol/l. CVVH was started and 300 ml/hr of fluid removed. The parasite count was 100/µl with less than 1% RBCs infected. He was acidotic, anaemic, thrombocytopaenic, hypoglycaemic, and had a leucocytosis of 18.8 x 10 9 /l. Intravenous quinine 450 mg tds was given in addition to meropenem 500 mg IV tds, and ciprofloxacin 300 mg IV bd. Melaena was present on rectal examination. Omeprazole 40 mg IV daily was prescribed and enteral feeding was withheld pending gastroscopy. His bilirubin was 128 µmol/l and his liver enzymes were mildly elevated. Granulocyte colony stimulating factor (g-CSF) was being used as part of an ongoing prospective trial to assess its efficacy in the treatment of septic shock in our intensive care unit. He received g-CSF 300 µg IV daily for the duration of his intensive care stay. On day 1 the parasite count had fallen to <100/µl. A gastroscopy showed mild gastritis and enteral feeding was commenced.
On day 2, his gas exchange worsened despite a negative daily fluid balance of 2500ml. The P a O 2 /FiO 2 ratio had fallen to 104 mmHg. Bronchoscopy and bronchoalveolar lavage were performed. His platelet count had fallen to 14 x 10 9 /l and he was oozing from puncture sites requiring frequent platelet transfusion.
On day six, liver function tests suggested an obstructive hepatitis. Ultrasound guided cholecystotomy was performed for acalculous cholecystitis. His parasitaemia persisted.
By day nine, inotropes had been weaned and ceased. All cultures were negative and he had been afebrile for two days. Intravenous antibiotics were ceased.
On day 10, a chest X-ray demonstrated an increase in alveolar infiltrates which was associated with a fever to 38.7°C. Nosocomial pneumonia due to Stenotrophomonas maltophilia was diagnosed and cotrimoxazole commenced. Malaria films were negative after 12 days. Quinine was ceased at this time.
A percutaneous tracheostomy was performed on day 14 and respiratory support weaned. On day 19, CVVH was replaced by intermittent haemodialysis and the tracheostomy was removed.
Patient 3 was discharged from the unit, on day 20, on intermittent haemodialysis. He was discharged from the hospital five days later, no longer requiring haemodialysis or supplemental oxygen.
Case 4
Patient 4, a 21-year-old Australian soldier, had been previously well, and was still taking daily 100 mg doxycycline prophylaxis. He had been unwell for four days with a fever, headache, vomiting and arthralgia beginning three days after returning from East Timor.
A diagnosis of falciparum malaria was made rapidly at the military hospital in Darwin and he was transferred to our unit for further care.
On admission to our intensive care unit his APACHE II score was 6 on the fourth day of his illness. His blood pressure was 116/42 mmHg with a pulse rate of 110 bpm. Oxygen saturation was 99% in room air with a respiratory rate of 16 bpm. Chest X-ray was normal. Neurological examination was normal. He had macroscopic haemoglobinuria which was strongly positive for blood and urobilinogen on urinalysis. Anaemia and thrombocytopaenia were present. He was febrile to 40.1°C with a parasite count of 65000/µl and 1.6% infected RBCs. Acute and convalescent serology indicated concurrent Dengue fever. A loading dose of intravenous quinine 1400 mg over four hours was administered on the day of his presentation. Quinine 700 mg IV tds was continued.
By day 4 malaria films were negative. His platelet count had risen to 35 x 10 9 /l. He was afebrile and able to tolerate oral quinine. He was discharged to the ward and then discharged from the hospital three days later.
Case 5
Patient 5, a 32-year-old Malaysian soldier, had been previously well. It was unclear if he was taking malaria prophylaxis. He presented with a one-day history of fever, headache, arthralgia and myalgia to the hospital in Dili. The diagnosis of a mixed infection of P. falciparum and P. vivax was made the next day. He was commenced on oral chloroquine and primaquine and admitted to a general ward. On day two it was noted that over 10% of RBCs were infected.
On day 4 he became tachypnoeic with a respiratory rate of 30 bpm, jaundiced and passed dark urine. He was transferred to their intensive care unit. Intravenous quinine 750 mg tds was commenced, following a loading dose of 1.5 g, four days after the diagnosis of falciparum was made. Blood tests showed a haemoglobin 125 g/l, white cell count 10.8 x 10 9 /l, platelets 8 x 10 9 /l, urea 32 mmol/l, creatinine 783 µmol/l, and bilirubin 177 µmol/l. On day 6, his respiratory rate increased to 50 bpm, he became anuric and spontaneous epistaxis occurred. He was intubated and evacuated to Darwin. He deteriorated in-flight and required an adrenaline infusion.
On admission to our unit his APACHE II score was 34 on the seventh day of his illness. Adrenaline was weaned and noradrenaline substituted at 0.2 µg/kg/min. CVP was 9 mmHg. The ECG showed a long QT interval and a new right bundle branch block. Intravenous quinine administration was withheld for eight hours until the ECG normalized. The dose of quinine was also reduced to 450 mg IV tds because of the acute renal failure. Chest X-ray confirmed left lower lobe consolidation. His P a O 2 /FiO 2 ratio was 250 mmHg. Urea was 44.4 mmol/l and creatinine was 1024 µmol/l. CVVH was commenced and a 50% dextrose infusion was started to treat hypoglycaemia. The parasite count was 120/µl and less than 1% RBCs were infected. Ticarcillin/ clavulanic acid 3.1 g IV tds, ciprofloxacin 200 mg IV tds and g-CSF 300 mg IV daily were started. Again, g-CSF was commenced as part of a trial taking place at the time of admission. He was sedated with morphine and midazolam. He coughed with suctioning and withdrew to painful stimuli. Pupils were 2 mm, equal, symmetrical and reactive.
Gas exchange deteriorated on day one. The P a O 2 /FiO 2 ratio fell to 135 mmHg. Inverse ratio pressure control ventilation was instituted along with a propofol infusion and regular IV pancuronium. His pupils were noted to be sluggishly reactive. CVVH removed 250 ml/h of fluid. He was tolerating enteral feeding and the parasite count had fallen to less than 100/µl. His blood sugar levels remained between 5 and 7.9 mmol/l.
On the morning of day 3, the left pupil was 2 mm and the right pupil had dilated to 3 mm. Both were unreactive. An urgent CT scan showed severe generalized cerebral oedema. The noradrenaline infusion was increased to 0.5 µg/kg/min to maintain the mean arterial pressure greater than 90 mmHg. Sedation with morphine and propofol was continued with regular pancuronium. P a CO 2 was held at 35 mmHg. He was actively cooled to 35°C. Boluses of hypertonic 3% sodium chloride solution were given to induce a hypernatraemia of between 150 and 155 mmol/l. Hypertonic saline, rather than mannitol, is used in our intensive care unit as osmotherapy for the treatment of raised intracranial pressure. An intraparenchymal intracranial pressure (ICP) monitor was inserted. ICP was initially measured at 50 mmHg. Phenobarbitone 1.2 g was administered which had no effect. Propofol was ceased and a thiopentone infusion at 750 mg/h was started and he was actively cooled to 32°C. CVVH continued to remove 200 ml/h of fluid.
By day 4, the chest X-ray showed bilateral lower lobe consolidation. Gas exchange remained poor with a P a O 2 /FiO 2 of 226 mmHg. ICP had stabilized at 25 mmHg. Cerebral perfusion pressure (CPP) was 70 mmHg but his pupils remained unequal and unreactive.
On day 5, the ICP again began to climb to a sustained 50 mmHg despite maximal medical therapy. Pupil size increased to 6 mm bilaterally. He was now requiring high dose inotropes.
On day 6, malarial films were finally negative but CPP fell to 30 mmHg and then to 2 mmHg in the evening. He became haemodynamically unstable and died on the morning of day 7.
DISCUSSION

Pathophysiology
Plasmodium species are very successful intravascular parasites of humans and are able to rapidly alter their antigenicity to evade the host immune defence system 6 . Plasmodium falciparum is particularly virulent compared to the other forms of malaria. The mortality rate for severe malaria remains around 20% in developed countries and may be as high as 80% if associated with acute respiratory distress syndrome (ARDS) [7] [8] [9] . P. falciparum is able to infect red cells of any age allowing amplification to occur rapidly. Over 50% of all erythrocytes may become infected 10 . Other Plasmodium species can only infect particular red cell sub-populations. For example, P. vivax can only invade reticulocytes. P. falciparum also sequesters in capillaries and post capillary venules of all organs. The infected cells adhere to the endothelium and uninfected erythrocytes (rosetting), evading clearance by the spleen and causing organ dysfunction. The exact mechanism of this organ dysfunction remains unclear but involves nitric oxide and impairment of gas and substrate exchange across the vessel wall 5, 11 . Cyclical erythrocyte rupture induces the release of pro-inflammatory cytokines such as tumour necrosis factor (TNF) and interleukins. The early nonspecific symptoms and signs of malaria are believed to be mediated by these cytokines. Excessively high concentrations of TNF may play a role in cerebral malaria due to TNF's ability to induce up-regulation of intercellular adhesion molecule (ICAM-1), and other receptors in cerebral endothelium, which facilitate cytoadhesion 12 . High TNF concentrations are associated with cerebral malaria and increased mortality in children 13 . Unfortunately, monoclonal anti-TNF antibodies were not shown to reduce mortality of children with severe malaria 14, 15 . A recent pilot study that examined the use of a polyclonal anti-TNF Fab fragment in adults was encouraging 16 .
Shock associated with malaria occurs in 30 to 45% of severe malaria in adults 8, 9 . Haemodynamic measurements demonstrate systemic vasodilation associated with a rise or fall in cardiac output 8, 17 . The aetiology of shock is multifactorial and includes dehydration, cytokine release and bacterial co-infection. Bacterial co-infection is common and may occur in over 50% of cases of shock associated with malaria 8, 17 . Bacteraemia at presentation may follow aspiration pneumonia or ischaemic damage of gastrointestinal mucosa. Shock was present on admission to our unit in three cases and all were treated with broad spectrum intravenous antibiotics.
Acute lung injury (ALI) may occur in up to 30% of patients with severe malaria 17 . It was present in four of the five cases. Two cases met the criteria for acute respiratory distress syndrome (ARDS) as defined in 1994 by the American-European Consensus Conference on ARDS 18 . ALI is considered the major cause of death in sophisticated intensive care units 9, 19 . The pathophysiology of ALI associated with malaria has yet to be defined. It may be a specific mechanism related to sequestration in the lung unique to P. falciparum. It could also be argued that septic shock and ARDS associated with severe malaria represents the body's non-specific response to any overwhelming endotoxin-mediated disease process 17 . Negative fluid balance is critical to avoid exacerbating acute lung injury but is balanced against the risk of precipitating acute renal failure. Pulmonary oedema exacerbating malarial ALI complicated cases 1, 2 and 3.
Cerebral malaria was difficult to diagnose on admission in our series as all patients, except patient 4, arrived intubated, paralysed and sedated. No patient strictly met the WHO criteria for cerebral malaria. Cerebral malaria accounts for 80% of malaria deaths in some parts of the world which may reflect limited access to methods of airway protection in those areas 20 . Our only fatality was due to uncontrolled raised intracranial pressure (ICP). Cerebral malaria is not usually associated with CT evidence of cerebral oedema or an elevated ICP 21 . An elevated ICP is uncommon and is considered an agonal event in cerebral malaria. Cerebral oedema is common at autopsy but is not invariable 22 . In regard to case 5, earlier administration of quinine may have altered his final outcome. This patient highlights the need for early diagnosis and the institution of appropriate treatment. The rise in mortality due to delays in instituting appropriate therapy is well documented 5, 8, 16, 22, 23 . Parasite amplification occurs quickly and results in a greater number of sequestered erythrocytes with each cycle. The consequences of sequestration may not be reversible when quinine is eventually started. Early commencement of therapy may reduce the total number of adherent mature trophozoites and subsequently reduce mortality 23 . If there is a clinical suspicion of malaria then thick blood films should be performed every 12 hours for 48 hours 24 .
Three patients in our series required renal support. The aetiology of renal failure associated with malaria includes dehydration, shock, parasite sequestration in renal vasculature and haemoglobinuria.
Hyperbilirubinaemia is commonly seen in severe malaria and is predominantly due to the haemolysis of parasitized erythrocytes 5 . It is not a marker for severe disease. Hepatic dysfunction is usually mild. Macroscopic gastrointestinal bleeding was seen in one patient and was probably related to mucosal ischaemia and thrombocytopaenia.
Haematological abnormalities are common. Thrombocytopaenia is not an indication of severity 5,9 . Anaesthesia and Intensive Care, Vol. 29, No. 4, August 2001 Disseminated intravascular coagulopathy is uncommon 5 .
Antimalarials
Quinine is an alkaloid derived from the bark of the Peruvian cinchona tree. It is currently the drug of choice for treating severe chloroquine-resistant falciparum malaria. Signs that malaria is slowly becoming resistant to quinine are now apparent in Southeast Asia and the Amazon Basin 25 .
Artemisinin and its derivatives, combined with doxycycline, are now being used for first-line treatment in Asia and the Amazon Basin 1, 26 . Artemisinin, a sesquiterpene lactone peroxide, is derived from the plant Artemisia annua (Qinghaosu). Qinghaosu has been used as a traditional Chinese medicinal remedy for fever for over 2000 years. Artemisinin has been used to treat malaria for the last 25 years in China and Southeast Asia. Artesunate and artemether, derivatives of artemisinin, have greater activity than their parent compound.
Artesunate is the water soluble sodium succinyl salt of artemisinin. It may be administered orally, rectally or parenterally. It is dispensed as a dry powder. One ampoule contains 60 mg artesunic acid and is mixed with a 5% solution of sodium bicarbonate before use. Artesunate is unstable in solution. It is considered to be a prodrug and biotransformation occurs to produce dihydroartemisinin which is biologically active. Elimination half-life of dihydroartemisinin is 45 minutes. The recommended dosage is 1.2 mg/kg bd following a loading bolus of 2.4 mg/kg intramuscularly or intravenously 24 .
Artemether is an oil-soluble methyl ether formulation of artemisinin in peanut oil, for intramuscular use only. It is more stable than artesunate and is as effective as intramuscular quinine 27, 28 .
These derivatives are potent inhibitors of early ring-stage parasites 28 . The mechanism of action is related to free radical damage to parasite membranes 29 . It has a shorter parasite clearance time compared to quinine. Clinical studies in children indicate that times to defervescence were reduced but the duration of coma was similar or prolonged compared to quinine 27, 28 . Artemether, compared to quinine, was also associated with an increased frequency of seizures amongst children with cerebral malaria 25 . Overall mortality from coma in children treated with either quinine or artemether was similar 27, 28 . In a randomized double-blind trial of 560 adults with severe malaria in Vietnam, artemether was associated with slower fever resolution and a longer recovery from coma, compared to quinine. There was a tendency towards reduced mortality with artemether which did not reach statistical significance. Artemisinin derivatives are associated with a higher recrudescence rate 29 and thus these drugs are usually combined with a seven day course of doxycycline.
Over two million people have been treated with these two artemisinin derivatives and no severe toxicity has been reported 30 .
Artemisinin derivatives are currently not registered in Australia. There is insufficient clinical data to comply with registration requirements in many countries 29 . It is an expensive drug to synthesize and yields from crops of Qinghaosu are low. Pharmaceutical companies are disinclined to market their products overseas unless the drug has passed registration requirements in their parent country. The market for antimalarial medication is small in developed nations and there is little profit from antimalarials distributed in developing countries 24 .
Exchange Blood Transfusion
No patient reported here underwent exchange transfusion although patient 3 received eight units of whole warm blood during resuscitation of his massive gastro-intestinal haemorrhage. The role of exchange transfusion in the treatment of severe malaria remains controversial. Its efficacy is still unproven. The advantages of exchange transfusion as an adjunct in the treatment of severe malaria include: 1. The rapid clearance of hyperparasitaemia which may reduce the number of infected red cells that go on to sequester. Dramatic decreases in parasite count to less than 1% RBCs infected after transfusion with eight to ten units of whole blood has been described 10,23 . 2. The clearance of excessive concentrations of malarial toxins and cytokines such as TNF may theoretically improve outcome 31, 32 . 3. The rapid correction of anaemia and coagulopathy if present.
There has been only one small prospective randomized control trial comparing antimalarial chemotherapy with and without adjuvant exchange transfusion 31 . This study by Saddler et al in 1986 found that all four patients who received antimalarial chemotherapy and exchange transfusion survived compared to only one survivor out of four patients who received chemotherapy alone. These results are encouraging but do not reach statistical significance. By 1996, over 100 other cases, treated by exchange transfusion, had been published as small retrospective case series or case reports 19 . A recent retrospective non-randomized German study of 124 patients found exchange transfusion did not improve outcome 19 .
The disadvantages of exchange transfusion include: 1. The need for skilled staff and a well equipped unit to perform the transfusion safely and avoid aggravating ALI by fluid overload. 2. The need for large volumes of valuable and scarce blood products. 3. The infection risk associated with blood products. 4. The risk of allowing therapeutic levels of quinine to fall during the exchange 10 . 5. The fact that exchange transfusion will have no effect on infected red cells that have already sequestered.
Confusion continues regarding what level of parasitaemia warrants transfusion. It is difficult to make firm recommendations. The relationship between parasite count and disease severity is complex. Partially immune patients may tolerate high levels of parasitaemia of 20% to 30% without clinical symptoms 26, 23 . Non-immune individuals may demonstrate low levels of parasitaemia in peripheral blood films which may not reflect extensive sequestration of mature schizonts responsible for end-organ damage. In extreme cases, cerebral malaria has been diagnosed at autopsy despite negative blood films. Two recent retrospective studies examining a total of 68 patients admitted to intensive care units found that parasite count was not a predictor of mortality 9, 17 .
Work by Field in the 1930s and 1940s did show a relationship between mortality and hyperparasitaemia in non-immune individuals. More recent studies confirm these findings 7, 34 . Burchant et al in 1997 found that case fatality increased rapidly when more than 10% of erythrocytes were infected 19 . WHO currently suggest that a parasite count of greater than 5% in a non-immune patient is associated with increased risk of severe disease 5 .
Salord et al recommend exchange transfusion if conventional treatment is failing after 36 hours regardless of the parasite count 23 . White wrote that "exchange transfusion should be performed if ... the patient is seriously ill and the parasitaemia exceeds 15%. Exchange should still be considered with parasitaemia in the range of 5 to 15% if there are other signs of poor prognosis" 24 . WHO recommends exchange transfusion in non-immune patients with evidence of organ dysfunction and a hyperparasitaemia greater than 10% 26 .
Mordmüller et al and Saddler et al state that exchange transfusion is experimental and should only be considered as part of a scientific study regardless of disease severity or level of parasitaemia 31, 35 . A powerful randomized controlled trial is still needed to clarify the issue.
CONCLUSION
These five cases illustrate that rapid diagnosis and early treatment of severe malaria is critical. Persistent severe lung injury is a common complication of severe malaria and fluid management must be precise.
With increasing numbers of people travelling internationally, the difficulties of controlling malaria in endemic areas, and the emergence of quinineresistant falciparum malaria, artemisinin derivatives may become useful worldwide.
The role of exchange transfusion remains unclear, but on the balance of opinion so far, it should be considered in any non-immune patient with evidence of organ dysfunction and a hyperparasitaemia greater than 10%.
